Effects of photobiomodulation on cellular viability and cancer stem cell phenotype in oral squamous cell carcinoma
- PMID: 32813258
- DOI: 10.1007/s10103-020-03131-x
Effects of photobiomodulation on cellular viability and cancer stem cell phenotype in oral squamous cell carcinoma
Abstract
Oral squamous cell carcinoma (OSCC) is the most common head and neck malignancy; it has been shown that cancer stem cells (CSC) are present in OSCC and associated with tumor growth, invasion, metastasis, and therapeutic resistance. Photobiomodulation (PBM) is an alternative tool for oncologic treatment adverse effects such as oral mucositis (OM); however, controversy exists regarding the undesirable effects of PBM on tumor or CSC. This study aimed to evaluate in vitro, the effects of PBM, with the same dosimetric parameters as those used in the clinic for OM prevention and treatment, on OSCC cellular viability, as well as PBM's effect on CSC properties and its phenotype. OSCC cell lines were submitted to single or daily PBM with 3 J/cm2 and 6 J/cm2 and then the cellular viability was evaluated by MTT, NRU (neutral red uptake), and CVS (crystal violet staining). The CSC populations were evaluated by clonogenic formation assay, flow cytometry, and RT-qPCR. The single PBM with the 3 J/cm2 group was associated with increased cellular viability. Daily PBM with 3 J/cm2 and 6 J/cm2 was associated with a significant decrease in cellular viability. Additionally, daily PBM was not able to promote CSC self-renewal or the CD44high/ESAlow and CD44high/ESAhigh cellular phenotypes. Moreover, a decrease in the number of spheres and in the expression of the CSC related gene BMI1 was observed after daily PBM with 6 J/cm2. Daily PBM with 3 J/cm2 and 6 J/cm2 showed an inhibitory effect on cellular viability and was not able to promote the CSC self-renewal or phenotype.
Keywords: Cancer stem cells; Low-level laser therapy; Oral squamous cell carcinoma; Photobiomodulation.
Similar articles
-
Photobiomodulation is associated with a decrease in cell viability and migration in oral squamous cell carcinoma.Lasers Med Sci. 2019 Apr;34(3):629-636. doi: 10.1007/s10103-018-2640-4. Epub 2018 Sep 19. Lasers Med Sci. 2019. PMID: 30232646
-
Effects of 5-ALA mediated photodynamic therapy in oral cancer stem cells.J Photochem Photobiol B. 2022 Oct;235:112552. doi: 10.1016/j.jphotobiol.2022.112552. Epub 2022 Sep 6. J Photochem Photobiol B. 2022. PMID: 36088836
-
Photobiomodulation effects on head and neck squamous cell carcinoma (HNSCC) in an orthotopic animal model.Support Care Cancer. 2020 Jun;28(6):2721-2727. doi: 10.1007/s00520-019-05060-0. Epub 2019 Nov 8. Support Care Cancer. 2020. PMID: 31705378 Free PMC article.
-
Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.Support Care Cancer. 2016 Jun;24(6):2793-805. doi: 10.1007/s00520-016-3153-y. Epub 2016 Mar 17. Support Care Cancer. 2016. PMID: 26984249 Free PMC article. Review.
-
Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations.Support Care Cancer. 2016 Jun;24(6):2781-92. doi: 10.1007/s00520-016-3152-z. Epub 2016 Mar 16. Support Care Cancer. 2016. PMID: 26984240 Free PMC article. Review.
Cited by
-
Photobiomodulation at molecular, cellular, and systemic levels.Lasers Med Sci. 2023 Jun 13;38(1):136. doi: 10.1007/s10103-023-03801-6. Lasers Med Sci. 2023. PMID: 37310556 Review.
-
Effects of photobiomodulation by low-power lasers and LEDs on the viability, migration, and invasion of breast cancer cells.Lasers Med Sci. 2023 Aug 23;38(1):191. doi: 10.1007/s10103-023-03858-3. Lasers Med Sci. 2023. PMID: 37610503
-
Cancer stem cells of head and neck squamous cell carcinoma; distance towards clinical application; a systematic review of literature.Am J Cancer Res. 2023 Sep 15;13(9):4315-4345. eCollection 2023. Am J Cancer Res. 2023. PMID: 37818051 Free PMC article. Review.
References
-
- Duprez F, Berwouts D, De Neve W, Bonte K, Boterberg T, Deron P, Huvenne W, Rottery S, Mareel M (2017) Distant metastases in head and neck cancer. Head Neck 39:1733–1743. https://doi.org/10.1002/hed.24687 - DOI - PubMed
-
- de Vicente JC, Rodríguez-Santamarta T, Rosado P, Peña I, de Villalaín L (2012) Survival after free flap reconstruction in patients with advanced oral squamous cell carcinoma. J Oral Maxillofac Surg 70:453–459. https://doi.org/10.1016/j.joms.2011.02.020 - DOI - PubMed
-
- Grégoire V, Lefebvre J-L, Licitra L, Felip E, Group ObotEEEGW (2010) Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21:184–186. https://doi.org/10.1093/annonc/mdq185 - DOI
-
- Vermorken JB, Specenier P (2010) Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol 21:252–261. https://doi.org/10.1093/annonc/mdq453 - DOI
-
- Nör C, Zhang Z, Warner KA, Bernardi L, Visioli F, Helman JI, Roesler R, Nör JE (2014) Cisplatin induces Bmi-1 and Enhances the stem cell fraction in head and neck cancer. Neoplasia 16:137–138. https://doi.org/10.1593/neo.131744 - DOI - PubMed - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous